You are on page 1of 62

Supplementary Training Modules on

Good Manufacturing Practice

Sterile Pharmaceutical Products

Annex 6. TRS 902, 2002

Sterile | Slide 1 of 62 January 2006


Sterile Production

Objectives

 To review basic GMP requirements in the manufacture of sterile


pharmaceutical products

 To review air classifications for activities related to the manufacture


of sterile products

 To review the different types of sterilization methods

 To review quality assurance aspects in the manufacture and control


of sterile products

 To consider current issues applicable in your country

Sterile | Slide 2 of 62 January 2006


Sterile Production

GMP Requirements for Sterile Products


 Additional rather than replacement

 Specific points relating to minimizing risks of


contamination
– microbiological
– particulate matter
– pyrogen

Sterile | Slide 3 of 62 January 2006


Sterile Production

General Considerations

 Production in clean areas

 Appropriate standard of cleanliness

 Filtered air supplied

 Airlocks for entry


– Personnel and/or equipment
– Materials

 Separate areas for operations


– component preparation (containers and closures)
– product preparation, filling, sterilization, etc. 1.1 – 1-2

Sterile | Slide 4 of 62 January 2006


Sterile Production

Premises

 Design
– Avoid unnecessary entry of supervisors and control personnel
– Operations observed from outside

 In clean areas, all exposed surfaces:


– Smooth, impervious, unbroken
– Minimize shedding and accumulation of particles, microorganisms
– Permit cleaning and disinfection
– No uncleanable recesses, ledges, shelves, cupboards, equipment
– Sliding doors undesirable
– False ceilings sealed 9.1 – 9.6

Sterile | Slide 5 of 62 January 2006


Sterile Production

Premises
 In clean areas, all exposed surfaces (2):
– Proper installation of pipes and ducts, no recesses, no
unsealed openings
– Sinks and drains avoided, and excluded in Grade A and B
areas
• Where installed, design, location, maintenance
• Effective cleanable traps
• Air breaks preventing backflow
• Floor channels open and easily cleanable
9.6.

Sterile | Slide 6 of 62 January 2006


Sterile Production
Premises

 Changing rooms
– Designed as airlocks
– Effective flushing with filtered air
– Separate rooms for entry and exit desirable
– Hand washing facilities
– Interlocking system for doors
– Visual and/or audible warning system

 Use filtered air supply to maintain pressure cascade

 Pressure differential approximately 10 to 15 Pascales

 Zone of greatest risk – immediate environment


9.7 – 9.9

Sterile | Slide 7 of 62 January 2006


Sterile Production

Premises

 Pathogenic, highly toxic, radioactive materials

 Pressure cascade may be different

 Decontamination procedures – air, equipment, garments

 Qualification including airflow patterns


– No risk to the product

 Warning system to indicate failure in air supply

 Pressure indicators – results regularly recorded

 Restricted access – e.g. use of barriers 9.9 – 9.12

Sterile | Slide 8 of 62 January 2006


Sterile Production

Equipment

 Conveyer belts

 Effective sterilization of equipment

 Maintenance and repairs from outside the clean area


– If taken apart, resterilized before use
– Use clean instruments and tools

 Planned maintenance, validation and monitoring


– Equipment, air filtration systems, sterilizers, water
treatment systems 10.1 – 10.5

Sterile | Slide 9 of 62 January 2006


Sterile Production

Equipment

 Water treatment plants and distribution system


– Design, construction, maintenance
– Operation and design capacity
– Testing programme

 Water for Injection (WFI)


– Produced, stored, distributed – prevention of growth of
microorganisms 10.6

– Constant circulation at temperature above 70, or not more


than 4 degrees Celsius
Sterile | Slide 10 of 62 January 2006
Sterile Production

Environmental Monitoring - I
Microbiological

 Air samples

 Surface swabs

 Personnel swabs

Sterile | Slide 11 of 62 January 2006


Sterile Production
Environmental Monitoring - II

Physical

 Particulate matter

 Differential pressures

 Air changes, airflow patterns

 Clean-up time/recovery

 Filter integrity

 Temperature and relative humidity

 Airflow velocity

Sterile | Slide 12 of 62 January 2006


Sterile Production

Sanitation

 Frequent, thorough cleaning of areas necessary

 Written programme

 Regular monitoring to detect resistant strains of microorganisms

 Chemical disinfection

 Monitoring of disinfectants and detergents

 Dilutions
– Clean containers, stored for defined periods of time 3.1 – 3.2
– Sterilized before use, when used in Grade A or B areas

Sterile | Slide 13 of 62 January 2006


Sterile Production

Sanitation

 Monitoring of clean areas

 Monitoring of personnel and surfaces after critical operations

 Frequent monitoring in areas where aseptic operations are carried


out
– Settle plates, volumetric air samples, surface sampling (swabs
and contact plates)
– Sampling methods should not contaminate the area

 Results considered when batch release is done


3.3

Sterile | Slide 14 of 62 January 2006


Sterile Production

Sanitation
 Limits of detection established
 Alert and action, and monitoring trends of air quality 3.4
Table 1. Limits for microbial contamination (Information only)

Grade Air sample Settle plates Contact plates Glove print


(CFU/m3) (90mm diameter) (55mm diameter) (5 fingers)
(CFU/4hours) (CFU/plate) (CFU/glove)
A <3 <3 <3 <3
B 10 5 5 5
C 100 50 25 -
D 200 100 50 -

Sterile | Slide 15 of 62 January 2006


Sterile Production
Personnel

 Minimum number of personnel in clean areas


– Especially during aseptic processing

 Inspections and controls from outside

 Training to all including cleaning and maintenance staff


– Initial and regular
– Manufacturing, hygiene, microbiology

 Special cases
– Supervision in case of outside staff
8.1tissue
– Decontamination procedures (e.g. staff who worked with animal – 8.3
materials)

Sterile | Slide 16 of 62 January 2006


Sterile Production

Personnel

 High standards of hygiene and cleanliness

 Periodic health checks

 No shedding of particles

 No introduction of microbiological hazards

 No outdoor clothing

 Changing and washing procedure


8.4 – 8.6
 No watches, jewellery and cosmetics

Sterile | Slide 17 of 62 January 2006


Sterile Production
Personnel

 Clothing of appropriate quality:


– Grade D
• hair, beard, moustache covered
• Protective clothing and shoes
– Grade C
• Hair, beard, moustache covered
• Single or 2-piece suit (covering wrists, high neck), shoes
• no fibres to be shed
– Grade A and B 8.7
• Headgear, beard and moustache covered, masks, gloves
• No shedding of fibres, and retain particles shed by operators

Sterile | Slide 18 of 62 January 2006


Sterile Production

Personnel

 Outdoor clothing not in change rooms leading to grade B and C


rooms

 Change at every working session, or once a day (if supportive data)

 Change gloves and masks at every working session

 Disinfect gloves during operations

 Washing of garments – separate laundry facility

 No damage, and according to validated procedures 8.8 – 8.9

Sterile | Slide 19 of 62 January 2006


Sterile Production

Group session 1
 You are asked to visit a factory producing the following
product lines:
– Injections in ampoules and vials, including insulin, vaccines and
heat-stable pharmaceuticals
– Sterile eye ointment

 Describe the type of facility you would expect to find

 List the typical rooms, their purpose and air classification

Sterile | Slide 20 of 62 January 2006


Sterile Production

Possible Issues

 Poor design of the building

 Poor design of the systems, e.g. water, HVAC

 Flow of personnel

 Flow of material

 No validation or qualification

 Old facilities not complying with current requirements

Sterile | Slide 21 of 62 January 2006


Sterile Production

Possible Issues (continued)


 Particulate levels/microorganisms

 Differential pressures

 Air changes

 Temperature/humidity

Sterile | Slide 22 of 62 January 2006


Sterile Production

Two categories of manufacturing operations:

 Terminally sterilized
– prepared, filled and sterilized

 Aseptic preparation
– some or all stages

1.3

Sterile | Slide 23 of 62 January 2006


Sterile Production

Manufacture of sterile preparations

 Classification of clean areas

 Manufacturing operation in an appropriate environment cleanliness


level

 Minimize risks – particulate and microbiological contamination –


product and material

 Meet classification "at rest"


– (i.e. "completed installation, equipment installed and operating,
but no operating personnel present").
4.1

Sterile | Slide 24 of 62 January 2006


Sterile Production

Manufacture of sterile preparations

 For sterile pharmaceutical preparations:

 Grade A
– Local zone, high risk operations, e.g. filling, aseptic connections
– Usually UDAF systems used

 Grade B
– Background environment to grade A (in case of aseptic preparation
and filling)

 Grade C and Grade D


4.1
– Clean areas for less critical operations

Sterile | Slide 25 of 62 January 2006


Sterile Production

Air Classification System

Grade At rest In operation


maximum permitted number of particles/m3
0.5 - 5.0 µm > 5 µm 0.5 - 5.0 µm >5µ
A 3 500 0 3 500 0
B 3 500 0 350 000 2 000
C 350 000 2 000 3 500 000 20 000
D 3 500 000 20 000 not defined not defined

3.1

Sterile | Slide 26 of 62 January 2006


Sterile Production
Manufacture of sterile preparations

 To reach Grade B, C and D, the number of air changes should be


appropriate to the size of the area, number of personnel, equipment
present

 Minimum of 20 air changes per hour

 Clean up time about 15-20 minutes

 Good airflow pattern in the area

 HEPA-filtered air

 Suitable methods to determine particulate matter and micro-


– e.g. EU, ISO, Japan, USA 4.1 – 4.2.

Sterile | Slide 27 of 62 January 2006


Sterile Production

Manufacture of sterile preparations

 Control particulate during operation

 Monitoring during operation

 Alert and action limits for particulate and micro

 Action taken when exceeded

 Area grades should be proven (e.g. validation runs, media fills,


environment, time limits – based on microbiological
contamination/bioburden found)
4.3 – 4.5

Sterile | Slide 28 of 62 January 2006


Sterile Production

Airborne particulate classification

WHO GMP US 209E US Customary ISO/TC (209) EEC GMP


Grade A M 3.5 Class 100 ISO 5 Grade A
Grade B M 3.5 Class 100 ISO 5 Grade B
Grade C M 5.5 Class 10 000 ISO 7 Grade C
Grade D M 6.5 Class 100 000 ISO 8 Grade D

4.1

Sterile | Slide 29 of 62 January 2006


Sterile Production

Processing

 Minimise contamination – all stages including before sterilization


and during processing

 No unsuitable materials, e.g. live microbiological organisms

 Minimize activities
– staff movement controlled and methodical
– avoid shedding of particles

 Temperature and humidity comfortable

 Containers and materials in the area


4.15 – 4.16, 4.20 – 4.21

Sterile | Slide 30 of 62 January 2006


Sterile Production
Processing
 Validation – should not compromise the processes
 Aseptic process validation: Sterile media fill (“broth fills”)
– Simulate actual operation – intimate as closely as possible
– Simulate worst expected condition
– Use appropriate medium/media
– Sufficient number of units - e.g. equal to batch size (small batches)
• acceptable limit
• investigations
– Revalidation: periodic and after change

 New processing procedures validated


– Revalidation after significant changes
– And regular intervals 4.17, 4.18, 4.28

Sterile | Slide 31 of 62 January 2006


Sterile Production

Processing

 Water sources, water treatment systems and treated water

 Monitored regularly
– Chemicals
– Biological contamination
– Endotoxin

 Water specification

 Records of results and action taken 4.19

Sterile | Slide 32 of 62 January 2006


Sterile Production

Processing

 Components, bulk product containers and equipment


– fibre generation
– no recontamination after final cleaning
– stage properly identified
– sterilized when used in aseptic areas

 Used in clean areas, passed through double-ended sterilizers or


use triple wrapping 4.22 – 4.23

 Gas used to purge solution or blanket a product – passed


through a sterilizing filter
Sterile | Slide 33 of 62 January 2006
Sterile Production

Processing

 Bioburden monitored
– Products: Before sterilization
– Working limits established
– Solutions to be filtered before filling (especially LVP)
– Pressure release outlets – hydrophobic microbiological air
filters

 Starting materials – microbiological contamination should be


minimal
4.26, 5.3
 Monitored as per specification
Sterile | Slide 34 of 62 January 2006
Sterile Production

Processing

 Time intervals: Components, bulk containers, equipment

 Washing and drying and sterilization; and sterilization and use


– As short as possible
– Time limit validated

 Time intervals: Product

 Start of preparation of solution and sterilization (filtration)


– As short as possible
– Maximum time set for each product
4.23 - 4.24

Sterile | Slide 35 of 62 January 2006


Sterile Production

Group session 2

 Considering the same factory as in the previous group session,


discuss the process of sterilization.

 List all the items that will need to be sterilized (and indicate the
choice of sterilization process).

 What are the key features you should find in each sterilization
situation?

 Discuss the relevance, need, and the extent of qualification and


validation required.

Sterile | Slide 36 of 62 January 2006


Sterile Production
Possible Issues

 Autoclave - no pressure gauge

 Autoclave - no temperature recorder

 Autoclave - superheated steam

 Clean room - pressure differentials

 Exposure for settle plates

 Interlocks turned off

 Rusty Laminar airflow cabinets

 HEPA filters not checked regularly

Sterile | Slide 37 of 62 January 2006


Sterile Production

Sterilization
 Methods of sterilization:
– Moist or dry heat
– Irradiation (ionizing radiation)
– Sterilizing gaseous agents (e.g. ethylene oxide)
– Filtration with subsequent aseptic filling

 Whenever possible: Terminal sterilization by heat in their


final container - method of choice
5.1 – 5. 2

Sterile | Slide 38 of 62 January 2006


Sterile Production
Sterilization
 Validation
– All sterilization processes
– Special attention when non-pharmacopoeia methods are used
– Non-aqueous or oily solutions
 Before the method is adopted – its suitability and efficacy
demonstrated with desired conditions:
– All parts of the load
– Each type of load
– Physical measurements and biological indicators (where
appropriate)
– Verified at least annually and after change
– Records maintained 5.4 – 5.5

Sterile | Slide 39 of 62 January 2006


Sterile Production

Sterilization
 For effective sterilization:

 Whole of the material subjected to the treatment

 Biological indicators:

 Additional method of monitoring

 Storage and use, quality checked through positive control

 Risk of contamination
5.6 - 5.7

Sterile | Slide 40 of 62 January 2006


Sterile Production
Sterilization
 Differentiation between sterilized and not-yet-sterilized products

 Each basket/tray or other carrier, properly labelled


– Name of material
– Batch number
– Sterilization status

 Use of autoclave tape

 Sterilization records for each run – approved as part of the batch


release procedure

5.8 - 5.9

Sterile | Slide 41 of 62 January 2006


Sterile Production

Terminal Sterilization
 Sterilization by heat

 Sterilization by moist heat

 Sterilization by dry heat

 Sterilization by radiation

 Sterilization by gases and fumigants


6

Sterile | Slide 42 of 62 January 2006


Sterile Production
Terminal Sterilization

Sterilization by heat

 Recording of each cycle, e.g. time and temperature chart


– Temperature: validated coolest part
– Check from second independent probe
– Additional chemical or biological indicators

 Heating phase: Sufficient time for the whole load


– Determined for each load

 Cooling phase: After sterilization cycle


– Precautions to prevent contamination
– Sterilized cooling fluid/gas
6.2 – 6.3

Sterile | Slide 43 of 62 January 2006


Sterile Production
Terminal Sterilization

Sterilization by moist heat (heating in an autoclave)

 Water-wetable materials only, and aqueous formulations

 Temperature, time and pressure monitored

 Temperature recorder independent of the controller

 Independent temperature indicator

 Drain – temperature recorded from this position

 Regular leak test when vacuum is part of the cycle

 Material allows for removal of air and penetration of steam

 All parts of the load in contact with steam

 Quality of the steam – no contamination

6.4 – 6.6

Sterile | Slide 44 of 62 January 2006


Sterile Production

Terminal Sterilization

Sterilization by dry heat

 For non-aqueous liquids, dry powders

 Air circulation in the chamber

 Positive pressure in chamber to prevent entry of non-sterile air

 HEPA filtered air supplied

 When removing pyrogens, challenge tests


– validation (using endotoxins)
6.7

Sterile | Slide 45 of 62 January 2006


Sterile Production
Terminal Sterilization
Sterilization by radiation
 Suitable for heat-sensitive materials and products
– confirm suitability of method for material
– ultraviolet irradiation not acceptable
 Contracting service – ensure validation status, responsibilities
 Measurement of dose during procedure
 Dosimeters independent of dose rate
– quantitative measurement
– number, location and calibration time-limit
 Biological indicators only as additional control
 Radiation sensitive colour discs

6.8 – 6.10

Sterile | Slide 46 of 62 January 2006


Sterile Production
Terminal Sterilization
Sterilization by radiation (2)
 Information forms part of the batch record

 Validation to cover effects of variation in density of packages

 Handling procedures to prevent misidentification of irradiated


and non-irradiated materials
 Each package to have a radiation-sensitive indicator
 Total radiation dose administered within a predetermined
period of time
6.10 – 6.13

Sterile | Slide 47 of 62 January 2006


Sterile Production
Terminal Sterilization
Sterilization by gases and fumigants
 Only when no other method is suitable
 e.g. ethylene oxide, hydrogen peroxide vapour
 Validation: Also prove the gas has no damaging effect on product
 Time and conditions for degassing (specified limits) - residue
 Direct contact with microbial cells essential
– Nature and quantity of packaging materials
 Humidity and temperature equilibrium
 Monitoring of each cycle with biological indicators
– time, pressure
– temperature, humidity and gas concentration 6.14 – 6.20

Sterile | Slide 48 of 62 January 2006


Sterile Production

Terminal Sterilization
Sterilization by gases and fumigants (2)

 Post-sterilization storage – controlled manner


– Ventilated conditions
– Defined limit of residual gas
– Validated process

 Safety and toxicity issues

6.21

Sterile | Slide 49 of 62 January 2006


Sterile Production

Terminally sterilized products


Grade Preparation Remark

D Components and product Ensure low microbial and


particulate count

C Product at unusual risk of e.g. product actively


microbial contamination supports microbial
growth, or
is held for a long period
of time before
sterilization, or
is not prepared mainly in
closed containers
C Filling before sterilization -

4.6 – 4.7

Sterile | Slide 50 of 62 January 2006


Sterile Production

Terminally sterilized products

Grade Preparation Remark

A in Filling before sterilization if e.g. slow filling


C background product at unusual risk of operation, or
contamination from Wide neck containers, or
environment Exposure for a few
seconds before sealing
C Preparation and filling Ointments, creams,
suspensions, emulsions

4.8 – 4.9

Sterile | Slide 51 of 62 January 2006


Sterile Production

Aseptic processing and sterilization by filtration


Aseptic processing

 Objective is to maintain the sterility of a product,


assembled from sterile components

 Operating conditions so as to prevent microbial


contamination

 What do you think are the aspects that require careful


attention? 7.1 – 7.2

Sterile | Slide 52 of 62 January 2006


Sterile Production
Aseptic processing and sterilization by filtration

Aseptic processing (2)

 Careful attention to:

 Environment

 Personnel

 Critical surfaces

 Container/closure sterilization

 Transfer procedures

 Maximum holding period before filling


7.3

Sterile | Slide 53 of 62 January 2006


Sterile Production

Aseptic preparation

Grade Preparation Remark

D Components after washing


C Preparation of solutions to be
sterile filtered later in the
process
A Preparation and filling of When the product is
(in B sterile ointments, creams, exposed and filtered
background) suspensions, emulsions

4.10, 4.11, 4.14

Sterile | Slide 54 of 62 January 2006


Sterile Production

Aseptic preparation
Grade Preparation Remark

A Sterile starting materials and (Unless subjected to


(in B components sterilization or filtration
background) through a microorganism
retaining filter later in the
process)
A Preparation of solutions (if
(in B not to be sterile filtered later)
background)
A Handling and filling of
(in B aseptically prepared
background) products,
A Handling of exposed sterile
(in B equipment
background)
A Transfer of partially closed e.g. in freeze drying
(in B containers, before complete (Grade B environment if
background) stoppering in sealed transfer trays)

Sterile | Slide 55 of 62 January 2006


4.10 – 4.13
Sterile Production

Sterilization by filtration

 Through a sterile filter of 0,22 µm or less, into previously sterilized


containers
– remove bacteria and moulds
– not all viruses or mycoplasmas

 Consider complementing with some degree of heat treatment

 Double filter layer or second filtration advisable, just before filling - no


fibre shedding or asbestos filters

 Filter integrity testing immediately after use


– also before use if possible
7.4 – 7.7

Sterile | Slide 56 of 62 January 2006


Sterile Production

Sterilization by Filtration (2)


 Validation to include
– Time taken to filter a known volume
– Pressure difference to be used across the filter

 Significant differences to be noted and investigated,


recorded in batch records

 Integrity of gas and air vent filters checked after use,


other filters at appropriate intervals
7.7

Sterile | Slide 57 of 62 January 2006


Sterile Production

Sterilization by Filtration (3)


 Same filter not used for more than one working day,
unless validated

 No filter interaction with product, e.g.


– removal of ingredients
– releasing substances into product

7.8 – 7.9

Sterile | Slide 58 of 62 January 2006


Sterile Production
Quality Control
 Samples for sterility testing should be representative
 From parts of the batch, most at risk
– Aseptic filling – at beginning and end of batch filling, and after
interruptions
– Heat sterilized – coolest part of the load
 Sterility of the batch ensured through validation
– Validated sterilization cycle
– Media fill
2.1 -2.2
 Sterility test procedure as per pharmacopoeia, and validated for each product
 Batch processing records, sterility testing records, environmental records
should be reviewed

Sterile | Slide 59 of 62 January 2006


Sterile Production

Quality Control
 Endotoxin testing for injectable products
– Water for injection, intermediate and finished product

 Always for large volume infusion solutions

 Pharmacopoeia method, validated for each product

 Failure of the test – investigation

 Corrective action 2.3

Sterile | Slide 60 of 62 January 2006


Sterile Production
Finishing of products

 Containers closed by means of validated methods

 Samples checked for integrity

 Maintenance of vacuum (where applicable) checked

 Parenteral products inspected individually

 Visual inspection under suitable and controlled conditions:


– illumination and background
– eyesight checks of operators
– allowed frequent breaks

 Other methods:
– validated, and equipment performance checked at intervals 11.1 – 11.3
– results recorded

Sterile | Slide 61 of 62 January 2006


Sterile Production

Group session 3
 Considering the same factory as in the previous group
sessions, devise a plan for monitoring of the facility.

 List the parameters to be tested, tests to be used,


acceptance criteria and frequency of testing.

Sterile | Slide 62 of 62 January 2006

You might also like